Funding the next scientific breakthrough for the world’s poor

June 12, 2012

At the Sabin Vaccine Institute, advocacy is big part of our business. We encourage politicians, philanthropists and the general public to expand immunization programs for vaccine-preventable diseases and increase treatment for over one billion people suffering from neglected tropical diseases.

But we’re also one of the few NGOs that is leading the research and development of vaccines to prevent diseases of poverty.

Sabin

Statement by Bill Gates on the Occasion of the World Health Assembly Resolutions Declaring Completion of Polio Eradication a Global Emergency and Endorsing the Global Vaccine Action Plan

SEATTLE -- “Today marks a huge victory in the fight to protect all children from vaccine-preventable diseases, no matter where they live."

Sabin

Statement of Support for New Global Vaccine Action Plan

May 25, 2012

The Sabin Vaccine Institute applauds the decision made today by the Sixty-fifth World Health Assembly to endorse the Global Vaccine Action Plan (GVAP). As a research and advocacy organization devoted to ensuring that life-saving vaccines reach the people that need them most, we commend this action plan, which lays the groundwork for the discovery, development and equitable delivery of vaccines.

Sabin

This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.

Pages

Subscribe to RSS - Sabin Vaccine Development